Skip to content
10-Q

Quarterly Report

SAGENT PHARMACEUTICALS, INC.

0001193125-16-575196

← back to feed
Filed
May 3, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2016 · Apr 29, 2016 32.84M sh
Shares Diluted Q1 2016 · Mar 31, 2016 32.83M sh
Shares Diluted Q1 2016 · Mar 31, 2015 32.04M sh
Capex Q1 2016 · Mar 31, 2016 $2.34M
Capex Q1 2016 · Mar 31, 2015 $2.24M
Long Term Debt Q1 2016 · Mar 31, 2016 $2.8M
Long Term Debt Q1 2016 · Dec 31, 2015 $1.62M
Short Term Investments Q1 2016 · Mar 31, 2016 $20.09M
Short Term Investments Q1 2016 · Dec 31, 2015 $20.06M
Cash And Equivalents Q1 2016 · Mar 31, 2016 $12.5M
Cash And Equivalents Q1 2016 · Dec 31, 2015 $28.96M
Cash And Equivalents Q1 2016 · Mar 31, 2015 $49.35M
Cash And Equivalents Q1 2016 · Dec 31, 2014 $55.63M
Stockholders Equity Q1 2016 · Mar 31, 2016 $253.45M
Stockholders Equity Q1 2016 · Dec 31, 2015 $251.09M
Current Liabilities Q1 2016 · Mar 31, 2016 $76.03M
Current Liabilities Q1 2016 · Dec 31, 2015 $83.66M
Total Liabilities Q1 2016 · Mar 31, 2016 $92.52M
Total Liabilities Q1 2016 · Dec 31, 2015 $98.64M
Current Assets Q1 2016 · Mar 31, 2016 $177.42M
Current Assets Q1 2016 · Dec 31, 2015 $191.59M
Total Assets Q1 2016 · Mar 31, 2016 $345.97M
Total Assets Q1 2016 · Dec 31, 2015 $349.73M
Eps Diluted Q1 2016 · Mar 31, 2016 −$0.15
Eps Diluted Q1 2016 · Mar 31, 2015 −$0.06
Eps Basic Q1 2016 · Mar 31, 2016 −$0.15
Eps Basic Q1 2016 · Mar 31, 2015 −$0.06
Sga Expense Q1 2016 · Mar 31, 2016 $12.12M
Sga Expense Q1 2016 · Mar 31, 2015 $13.13M
Rd Expense Q1 2016 · Mar 31, 2016 $6.76M
Rd Expense Q1 2016 · Mar 31, 2015 $5.32M
Net Income Q1 2016 · Mar 31, 2016 −$4.99M
Net Income Q1 2016 · Mar 31, 2015 −$1.89M
Operating Income Q1 2016 · Mar 31, 2016 −$7.22M
Operating Income Q1 2016 · Mar 31, 2015 −$189K
Gross Profit Q1 2016 · Mar 31, 2016 $16.85M
Gross Profit Q1 2016 · Mar 31, 2015 $21.93M
Cost Of Revenue Q1 2016 · Mar 31, 2016 $50.95M
Cost Of Revenue Q1 2016 · Mar 31, 2015 $60.72M